Gunn George W 4
4 · Nexvet Biopharma plc · Filed Aug 2, 2017
Insider Transaction Report
Form 4
Gunn George W
Director
Transactions
- Disposition to Issuer
Ordinary Shares
2017-07-31$6.72/sh−42,600$286,272→ 0 total - Disposition to Issuer
Restricted Share Units
2017-07-31$6.59/sh−1,500$9,893→ 0 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (1,500 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to a transaction agreement between the Issuer, Zoetis Inc. ("Zoetis") and Zoetis Belgium S.A., a wholly-owned subsidiary of Zoetis ("Bidco"), pursuant to which Bidco acquired the Issuer.
- [F2]This restricted share unit, which would have vested and become convertible as to 500 shares on each of 9/30/17, 12/31/17 and 3/31/18, in each case subject to payment of the nominal value per share of $0.125 to the Issuer within 30 days of vesting, was cancelled in the Acquisition in exchange for a cash payment equal to $9,892.50. This amount represents the difference between such nominal value per share and the $6.72 consideration per share payable in connection with in the Acquisition, multiplied by the number of shares issuable on conversion of the restricted share unit.